Syneos Health Communications Adds New Talent in Europe, Enhancing Core Integrated Offerings
Senior Leaders Bring Added Depth to Market Access, Scientific and Medical, and Creative Capabilities
Read ArticleThe diverse European healthcare environment requires a specific approach to communications
The European market provides multiple challenges to the pharmaceutical industry, emerging biotechnology and medical technology firms who develop, launch and commercialize drugs and devices.
Deep and varied local and international insights, experience, capabilities and footprints are required for impactful healthcare communications in Europe because of the high diversity in local regulations, health systems, market dynamics, key stakeholders’ perceptions, as well as cultural nuances and languages.
A next-generation agency group that offers the perfect combination of global size and unprecedented capabilities with European and local expertise
As a part of Syneos Health, the only global biopharmaceutical accelerator integrating clinical development, real-world, late-stage and full commercialization, we serve the complex European healthcare market with tailored communications solutions for our clients’ clinical and commercial success.
Our key principles:
250+ European healthcare communications experts integrating their medical communications, PR, advertising and digital/multichannel expertise serve the 20 most important markets in Europe. Their unlimited access to Syneos Health global insights, therapeutic area expertise from mass to rare, and analytical assets allows us to develop unique, value-driven, scalable and measurable communications solutions tailored to Europe.
Our colleagues across Europe also bring diversity of thought — not just because of their French, German, British and other cultural codes — but as philosophers, six-sigma-level processors, and critical thinkers. Our team includes journalists, scientists, artists, data geeks and digital innovators — all sharing a desire to help our clients accelerate the benefits they can bring to doctors and patients.
Our capabilities include:
Medical Communications
Public Relations
Advertising
Senior Leaders Bring Added Depth to Market Access, Scientific and Medical, and Creative Capabilities
Read ArticleListen to our podcast with Jessica Shull, European Lead for the Digital Therapeutics Alliance, an international non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics.
Read ArticleSpeed & Scale in the Great Disruption. As we worked with providers, innovators and experts around the world to understand the trends most likely to drive change in life science clinical and commercial engagement, twenty quickly stood out.
Read ArticleAlready have a RSS feed reader?